Navigation Links
Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
Date:2/4/2008

LIVINGSTON, N.J., Feb. 4 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that Scott Mahnken has joined the Company's leadership team as new Director of Marketing. Tasked with developing and managing a wide range of strategic marketing and communications initiatives to promote corporate and product brand awareness and drive sales growth, Mahnken will report directly to Bob Presutti, Vice President of Sales and Marketing.

"Scott is a welcome addition to our team, bringing significant marketing expertise, important industry contacts and relationships, and a 20+ year proven history of success in achieving tangible, impressive results. His experience within the professional dental industry coupled with his demonstrated ability to drive sales through innovative, proactive marketing programs is sure to play a measurable role in aiding Milestone to advance its strategic growth objectives," noted Presutti. "We are particularly excited about Scott helping us to adopt more effective methods of using outbound telemarketing to promote greater customer support and product education, while also increasing sales of our disposable handpieces."

Immediately prior to joining Milestone, Mahnken served as Director of Partnership Relations at ArcMesa Educators, an organization dedicated to providing accredited continuing education to medical and dental providers. From 2000 through 2003, he served as Manager of Sales and Marketing and Product Manager of SS White Burs, Inc., the nation's oldest dental equipment manufacturer. While serving as Director of Sales at Lanmark Group, Inc. from 1994 through 2000, Mahnken managed the medical/dental ad agency's clients' inside and outside product sales initiatives where he doubled sales the first year and achieved 20% sales growth every year thereafter. From 1985 through 1994, he served as District Sales Manager for L'Oreal,
'/>"/>

SOURCE Milestone Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
2. Milestone Scientific Commences Declaratory Judgment Action With Respect to Its Single Tooth Anesthesia (STA(TM)) System and Compudent(TM) System
3. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
4. Milestone Scientific to Exhibit the STA(TM) System at the American Dental Associations 148th Annual Session in San Francisco
5. Smurfit-Stones Hodge, LA, Mill Becomes First to Achieve Safety Milestone
6. Grand Opening of Regence Boys & Girls Club Marks a Milestone in Historic New Columbia Community Revitalization
7. Milestone Scientific to Present at the Edgewater Research Investor Conference
8. Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
9. Global Gene Map Clears New Milestone
10. Free Site Offering Patient-Physician Dialog Reaches Milestone
11. Marlo Thomas and St. Jude Childrens Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)... Voyant Health™ announced toda...s licensed its TraumaCad Enterprise orthopedic tem... solution. , (PRWEB) Nove...day that Spectrum Health (Grand Rapids, Michigan) ...emplating solution and its TraumaCad Extend workfl...
(Date:11/26/2009)...NCETON,N.J.,Nov.27/PRNewswire/--Thediabetespopulat...earsandannualmedicalspendingonthediseaseisprojecte...toastudypublishedintheDecemberissueof DiabetesCare...,aprogramofNovoNordisk,commissionedtheanalysisbyat...eforecast,thenumberofAmericanslivingwithdiabeteswi...
(Date:11/26/2009)... No more letters from the North Pole...zed text messages from Santa , ...crease operational efficiencies at the North Pole ...eep children all over the globe informed of his Ch...anta’s research department have identified a...
(Date:11/25/2009)...NA,Minn.,Nov.25/PRNewswire-USNewswire/--Whenmostpe...chiropractorcanalsogivepatientsthehelptheyneed.TMJ...ourjaw(mandible)contacts/connectswithyourskull(tem...ithTMJdysfunctionarepainwithchewing,clickingorpopp...dysfunctionincluding:headaches,fatigue,sleepdistur...
(Date:11/25/2009)...GBEACH,Calif.,Nov.25/PRNewswire/--Thanksgivingmeal...rsinthegreaterLongBeachareathankstoFaithInAction/V...nceatHome(IAH),adivisionofSCANHealthPlan.Formoreth...olunteerstodeliverwarmThanksgivingmealstoseniorsin...LosAngelesandsurroundingcities. ,, "Ourwarmholi...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...better part of three decades, Sherrie Kossoudji ha... chronic pain, tight joints and other types of phy... Rheumatoid arthritis affects my life in as many ... ever really go away. Now 53, Kossoudji i...
...S president Bill Clinton has once again lent a hel...between the Brazil government and drug giant Merc...oundation has helped diffuse the situation. Clinc... drugs and a next generation one-pill-a-day drug. ...
... used diabetes drug dramatically boosted the poten...d together to a variety of cancer cell lines and ...ancer Institute report. Combining a platinum ...given alone, according to the article in the May i...
...excitation through suppressing communication betwe... such as epilepsy and schizophrenia. Rese...pitched upon a protein that could do the trick. Th...he key to tackling diseases such as epilepsy and s...
...perhaps the first clinical study that relates the ...he rescuers, due to inhalation of dust and pollut...m to be suffering a rare type of lung condition wh...d that 13 firefighters and emergency medical servi...
... who took in 100 percent juice, consumed more of f...lt and sugars as compared to those who didnt do a...t but in keeping good health. A new study conducte...th survey conducted from 1999 to 2002 and studying...
Other Medicine News:Health News:Aging Gracefully, With a Chronic Disease 2Health News:Clinton Foundation Eases Over-Pricing Of AIDS Drugs Once More 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 2Health News:Diabetes Drug Dramatically Boosts Potency of Platinum Chemotherapy 3Health News:British Scientists Discover New Protein to Treat Epilepsy and Schizophrenia 2
(Date:11/25/2009).../PRNewswire-FirstCall/--HeartWareInternational,Inc...deroflessinvasive,miniaturizedcirculatorysupportte...rtfailure,todayannouncedthatitisscheduledtomakeani...thCareConferenceat8:00amESTonWednesday,December2,2...l,December1-2. ,, AlivewebcastoftheCompany,spre...
(Date:11/24/2009)...FirstCall/--Endologix,Inc.(Nasdaq: ELGX ),develope...nnouncedtodaythatithasfiledamotiontostay,ordiscont...roughtagainstitinOctober2009byCook,Inc.Themotionwa...,Indiana. ,, Endologixhasrequestedthatthestayre...Office(USPTO)conductsproceedingstore-examinethetwo...
(Date:11/24/2009)....24/PRNewswire/-- EisaiInc.andPfizerIncannouncedt...ceptedforreviewEisai,sNewDrugApplication(NDA)foron...se)tabletsforthetreatmentofmoderatetosevereAlzheim...ns23mgofdonepezilHClinanextendedrelease,matrix-typ...aseofthedrug.TheNDAisbasedonahead-to-headclinicals...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento 5753 1American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento 5753 2American Lung Association of California Joins Sheriffs Department to Support Influenza Vaccination In Sacramento 5753 3Adding tools against breast tumors 60167 1URI research couples method targets cancerous tumors 60165 1URI research couples method targets cancerous tumors 60165 2URI research couples method targets cancerous tumors 60165 3URI research couples method targets cancerous tumors 60165 4
... Findings Reported on Glucose Homeostasis Effects ...2007 /PRNewswire-FirstCall/ -- In a 14-day,Phase ...of the,investigational compound dapagliflozin, a s...er 2 (SGLT2) administered alone or,concomitantly w...,discontinuations due to adverse events and no ser...
..., June 25, 2007 /PRNewswire/ -- Novagali Pharma, a...phthalmology,presents positive results of its pivo... the Phase III clinical study of Vekacia(R) in,chi...VKC) at the,XIV Afro-Asian Congress of ophthalmolo...h (Morocco). , VKC is a severe form of chronic all...
Other Medicine Technology:First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 2First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 3First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 4First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 5First Phase II Short-Term Study on Dapagliflozin Shows Results on,Safety, Tolerability and Glycemic Markers in Subjects With Type 2,Diabetes 6Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 2Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 3Novagali Pharma Presents at AACO the Results of its Pivotal Phase,III Clinical Trial of Vekacia in Children Suffering From Vernal,Keratoconjunctivitis 4
KERASPEAR Eye Spear
Weck-Cel Spears
Merocel Instrument Wipe
Merocel Eye Wicks (8") with 400cc Collection Bag
Medicine Products: